Filing Flows › Orthofix Medical (OFIX) › Q1 FY26 › vs Q1 FY25
Orthofix Medical (OFIX) Q1 FY26 vs Q1 FY25 (year over year)
Orthofix Medical's revenue rose $3.1M (+2%) from $194M in Q1 FY25 to $197M in Q1 FY26. The biggest changes: Global Limb Reconstruction +$3.0M (+10%); Global Spine +$16K (0%).
Orthofix Medical, Q1 FY26: revenue $197M (+2% year over year), operating margin -7.3%, net loss $20.9M, operating cash flow −$17.6M. The chart draws each line against Q1 FY25, the increases inside each band.
Every line
| Line | Q1 FY26 | Q1 FY25 | Change | % |
|---|---|---|---|---|
| Global Spine | $164M | $164M | $16K | 0% |
| Global Limb Reconstruction | $32.9M | $29.8M | $3.0M | +10% |
| Revenue | $197M | $194M | $3.1M | +2% |
| Net loss | $20.9M | $53.1M | −$32.2M | -61% |
| Costs & expenses | $218M | $247M | −$29.1M | -12% |
| Operating costs | $211M | $243M | −$31.4M | -13% |
| Interest & other, net | $6.4M | $3.3M | $3.1M | +96% |
| Income tax | $74K | $961K | −$887K | -92% |
| Cost of revenue | $57.2M | $72.0M | −$14.9M | -21% |
| Research & development | $15.3M | $19.8M | −$4.4M | -22% |
| SG&A | $135M | $133M | $1.9M | +1% |
| Other operating costs | $3.8M | $17.7M | −$14.0M | -79% |
| Operating cash sources | $37.6M | $59.3M | −$21.7M | -37% |
| Depreciation & amortization | $13.5M | $34.4M | −$20.9M | -61% |
| Share-based compensation | $6.5M | $6.5M | $64K | +1% |
| Cash used in operations | $17.6M | $18.4M | −$781K | -4% |
| Net loss absorbed | $20.9M | $53.1M | −$32.2M | -61% |
| Working capital & other | $16.7M | $6.2M | $10.5M | +170% |
Questions
How much did Orthofix Medical's revenue grow year over year in Q1 FY26?
Orthofix Medical's revenue rose $3.1M (+2%) from $194M in Q1 FY25 to $197M in Q1 FY26.
What drove Orthofix Medical's revenue change in Q1 FY26?
Global Limb Reconstruction +$3.0M (+10%); Global Spine +$16K (0%).